PlainRecalls
FDA Drug Moderate Class II Ongoing

Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.

Reported: April 30, 2025 Initiated: April 2, 2025 #D-0369-2025

Product Description

Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.

Reason for Recall

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Details

Units Affected
143 1x5 vials
Distribution
Nationwide in the USA
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.. Recalled by Amerisource Health Services LLC. Units affected: 143 1x5 vials.
Why was this product recalled?
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Which agency issued this recall?
This recall was issued by the FDA Drug on April 30, 2025. Severity: Moderate. Recall number: D-0369-2025.